Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Cash & Equivalents (2016 - 2022)

Inogen (INGN) has disclosed Cash & Equivalents for 11 consecutive years, with $209.6 million as the latest value for Q3 2022.

  • On a quarterly basis, Cash & Equivalents fell 13.22% to $209.6 million in Q3 2022 year-over-year; TTM through Sep 2022 was $209.6 million, a 13.22% decrease, with the full-year FY2021 number at $235.5 million, up 11.12% from a year prior.
  • Cash & Equivalents was $209.6 million for Q3 2022 at Inogen, down from $223.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $241.6 million in Q3 2021 to a low of $166.3 million in Q2 2018.
  • A 5-year average of $213.7 million and a median of $213.7 million in 2020 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 37.55% in 2018, then decreased 13.22% in 2022.
  • Inogen's Cash & Equivalents stood at $196.6 million in 2018, then grew by 0.71% to $198.0 million in 2019, then grew by 7.03% to $212.0 million in 2020, then increased by 11.12% to $235.5 million in 2021, then dropped by 10.99% to $209.6 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Cash & Equivalents are $209.6 million (Q3 2022), $223.6 million (Q2 2022), and $213.4 million (Q1 2022).